Armata Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q3 2024.
  • Armata Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $670K.
  • Armata Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.73M, a 74.9% increase year-over-year.
  • Armata Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $938K, a 69.8% decline from 2022.
  • Armata Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.11M, a 7.74% increase from 2021.
  • Armata Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.88M, a 17.1% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.73M $670K +$1.04M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.69M $1.34M +$1.07M +411% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $615K $534K -$323K -37.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $938K $193K -$624K -76.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.56M -$373K -$1.22M -144% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $2.78M $261K -$688K -72.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $3.47M $857K +$364K +73.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $3.11M $817K +$153K +23% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $2.95M $846K +$377K +80.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.58M $949K +$42K +4.63% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.53M $493K -$349K -41.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $2.88M $664K -$198K -23% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $3.08M $469K -$194K -29.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $3.27M $907K +$1K +0.11% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.27M $842K -$202K -19.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.48M $862K -$87K -9.17% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $3.56M $663K -$1.84M -73.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $5.4M $906K +$182K +25.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $5.22M $1.04M +$945K +955% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $4.27M $949K +$1.05M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $3.22M $2.5M +$2.49M +31125% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $734K $724K +$711K +5469% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $23K $99K -$23K -18.9% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $46K -$97K -$229K -173% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 $275K $8K -$90K -91.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $365K $13K -$286K -95.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $651K $122K -$49K -28.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $700K $132K -$165K -55.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-25
Q3 2017 $865K $98K -$236K -70.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.1M $299K -$249K -45.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.35M $171K -$645K -79% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $2M $297K +$67K +29.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 $1.93M $334K +$185K +124% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $1.74M $548K +$496K +954% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $1.25M $816K +$764K +1469% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $483K $230K +$171K +290% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-27
Q3 2015 $312K $149K -$1.26M -89.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $1.57M $52K -$183K -77.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $1.75M $52K -$182K -77.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $1.94M $59K -$173K -74.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 $2.11M $1.41M +$1.16M +468% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $949K $235K -$568K -70.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $1.52M $234K +$80K +51.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $1.44M $232K Oct 1, 2013 Dec 31, 2013 10-K 2015-04-15
Q3 2013 $248K Jul 1, 2013 Sep 30, 2013 10-Q/A 2015-04-15
Q2 2013 $803K Apr 1, 2013 Jun 30, 2013 10-Q/A 2015-04-15
Q1 2013 $154K Jan 1, 2013 Mar 31, 2013 10-Q/A 2015-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.